• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

介导RINm5F胰岛素瘤细胞中胰岛素分泌抑制作用的生长抑素受体的特性分析。

Characterization of somatostatin receptors which mediate inhibition of insulin secretion in RINm5F insulinoma cells.

作者信息

Sullivan S J, Schonbrunn A

出版信息

Endocrinology. 1987 Aug;121(2):544-52. doi: 10.1210/endo-121-2-544.

DOI:10.1210/endo-121-2-544
PMID:2885182
Abstract

Somatostatin (SRIF) is a neuropeptide which inhibits secretion from a variety of target cells including pancreatic beta-cells. In this study we have used the RINm5F rat insulinoma cell line to characterize high affinity receptors for SRIF. The binding of 0.03 nM [125I-Tyr11]SRIF to RINm5F cells reached a plateau level within 4 h at 37 C at which time 80% of the total binding could be displaced by 100 nM unlabeled SRIF. In contrast, 100 nM concentrations of eight structurally unrelated peptides did not inhibit [125I-Tyr11]SRIF binding. Scatchard analysis indicated that RINm5F cells contained a single class of noninteracting binding sites (910 +/- 190 sites per cell) with high affinity for [125I-Tyr11]SRIF [equilibrium dissociation constant (Kd) = 0.04 +/- 0.01 nM]. Competition experiments with SRIF analogs showed that the binding affinity for [I-Tyr11]SRIF (Kd = 0.03 +/- 0.02 nM) was higher than that for either SRIF (0.24 +/- 0.04 nM) or [Tyr11]SRIF (0.27 +/- 0.04 nM) and that reduced SRIF analogs bound poorly (Kd greater than 50 nM). These results demonstrate that RINm5F cells possess specific, high affinity binding sites for SRIF. Insulin release stimulated by 20 mM leucine or 15 mM glyceraldehyde was inhibited as much as 80% by maximal concentrations (100 nM) of SRIF. The IC50 for SRIF inhibition of leucine-stimulated insulin secretion was 0.43 +/- 0.15 nM, in good agreement with the apparent Kd for binding. In fact, this close correlation between binding affinity and potency to inhibit insulin release was observed for six SRIF analogs, indicating that the characterized binding sites are the receptors which mediate the biological actions of SRIF in RINm5F cells.

摘要

生长抑素(SRIF)是一种神经肽,可抑制包括胰腺β细胞在内的多种靶细胞的分泌。在本研究中,我们使用RINm5F大鼠胰岛素瘤细胞系来表征SRIF的高亲和力受体。0.03 nM [125I-酪氨酸11]SRIF与RINm5F细胞的结合在37℃下4小时内达到平台期,此时100 nM未标记的SRIF可取代80%的总结合。相比之下,100 nM浓度的八种结构不相关的肽并未抑制[125I-酪氨酸11]SRIF的结合。Scatchard分析表明,RINm5F细胞含有一类单一的非相互作用结合位点(每个细胞910±190个位点),对[125I-酪氨酸11]SRIF具有高亲和力[平衡解离常数(Kd)=0.04±0.01 nM]。用SRIF类似物进行的竞争实验表明,对[I-酪氨酸11]SRIF(Kd = 0.03±0.02 nM)的结合亲和力高于对SRIF(0.24±0.04 nM)或[酪氨酸11]SRIF(0.27±0.04 nM)的结合亲和力,并且还原的SRIF类似物结合较差(Kd大于50 nM)。这些结果表明,RINm5F细胞具有SRIF的特异性高亲和力结合位点。20 mM亮氨酸或15 mM甘油醛刺激的胰岛素释放被最大浓度(100 nM)的SRIF抑制多达80%。SRIF抑制亮氨酸刺激的胰岛素分泌的IC50为0.43±0.15 nM,与结合的表观Kd良好吻合。事实上,六种SRIF类似物均观察到结合亲和力与抑制胰岛素释放效力之间的这种密切相关性,表明所表征的结合位点是介导SRIF在RINm5F细胞中生物学作用的受体。

相似文献

1
Characterization of somatostatin receptors which mediate inhibition of insulin secretion in RINm5F insulinoma cells.介导RINm5F胰岛素瘤细胞中胰岛素分泌抑制作用的生长抑素受体的特性分析。
Endocrinology. 1987 Aug;121(2):544-52. doi: 10.1210/endo-121-2-544.
2
Distribution of somatostatin receptors in RINm5F insulinoma cells.生长抑素受体在RINm5F胰岛素瘤细胞中的分布
Endocrinology. 1988 Mar;122(3):1137-45. doi: 10.1210/endo-122-3-1137.
3
The processing of receptor-bound [125I-Tyr11]somatostatin by RINm5F insulinoma cells.
J Biol Chem. 1986 Mar 15;261(8):3571-7.
4
Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.[酪氨酸11]生长抑素的碘化产生了一种对GH4C1垂体细胞中生长抑素受体具有超高亲和力的配体。
Mol Pharmacol. 1988 Nov;34(5):651-8.
5
Characterization of covalently cross-linked somatostatin receptors in hamster beta cell insulinoma.
Eur J Biochem. 1988 May 16;174(1):219-24. doi: 10.1111/j.1432-1033.1988.tb14085.x.
6
Specific high affinity binding sites for somatostatin-28 on pancreatic beta-cells: differences with brain somatostatin receptors.
Endocrinology. 1982 Mar;110(3):1049-51. doi: 10.1210/endo-110-3-1049.
7
Characterization of a biotinylated somatostatin analog as a receptor probe.一种生物素化生长抑素类似物作为受体探针的特性研究。
Endocrinology. 1993 Jan;132(1):146-54. doi: 10.1210/endo.132.1.8093437.
8
Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis.生长抑素激动剂与脑和腺垂体中生长抑素受体的差异性结合。
Neuroendocrinology. 1987 Jun;45(6):429-36. doi: 10.1159/000124788.
9
Pancreatic beta-cell somatostatin receptors.胰腺β细胞生长抑素受体
Am J Physiol. 1990 Aug;259(2 Pt 1):E216-24. doi: 10.1152/ajpendo.1990.259.2.E216.
10
Identification of somatostatin receptors by covalent labeling with a novel photoreactive somatostatin analog.
J Biol Chem. 1990 Oct 15;265(29):17995-8004.